Eaton Vance Management’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $32.6M | Sell |
216,409
-54,731
| -20% | -$9.11M | 0.05% | 342 |
|
|
2022
Q2 | $44.6M | Buy |
271,140
+5,797
| +2% | +$1.12M | 0.06% | 290 |
|
|
2022
Q1 | $59.1M | Buy |
265,343
+82,861
| +45% | +$18.6M | 0.07% | 278 |
|
|
2021
Q4 | $43.3M | Buy |
182,482
+2,132
| +1% | +$498K | 0.05% | 325 |
|
|
2021
Q3 | $42M | Sell |
180,350
-114,337
| -39% | -$24M | 0.06% | 291 |
|
|
2021
Q2 | $60.6M | Buy |
294,687
+4,972
| +2% | +$1.02M | 0.08% | 236 |
|
|
2021
Q1 | $59.5M | Buy |
289,715
+5,820
| +2% | +$1.23M | 0.09% | 225 |
|
|
2020
Q4 | $60.9M | Buy |
283,895
+17,725
| +7% | +$3.44M | 0.1% | 206 |
|
|
2020
Q3 | $48.6M | Sell |
266,170
-30,791
| -10% | -$5.8M | 0.09% | 214 |
|
|
2020
Q2 | $54.7M | Buy |
296,961
+56,362
| +23% | +$11.2M | 0.11% | 174 |
|
|
2020
Q1 | $48.5M | Buy |
240,599
+88,974
| +59% | +$17.1M | 0.12% | 165 |
|
|
2019
Q4 | $28.4M | Buy |
151,625
+21,070
| +16% | +$3.63M | 0.06% | 276 |
|
|
2019
Q3 | $20.8M | Buy |
130,555
+1,128
| +0.9% | +$225K | 0.04% | 300 |
|
|
2019
Q2 | $32.6M | Buy |
129,427
+9,821
| +8% | +$2.28M | 0.07% | 246 |
|
|
2019
Q1 | $28.6M | Buy |
119,606
+11,002
| +10% | +$2.64M | 0.07% | 252 |
|
|
2018
Q4 | $24.9M | Buy |
108,604
+155
| +0.1% | +$38.2K | 0.06% | 246 |
|
|
2018
Q3 | $30.7M | Buy |
108,449
+24,909
| +30% | +$7.3M | 0.07% | 240 |
|
|
2018
Q2 | $24.5M | Sell |
83,540
-74,610
| -47% | -$20.4M | 0.06% | 255 |
|
|
2018
Q1 | $39.9M | Buy |
158,150
+79,126
| +100% | +$18.6M | 0.05% | 275 |
|
|
2017
Q4 | $17.1M | Buy |
79,024
+4,954
| +7% | +$1M | 0.04% | 301 |
|
|
2017
Q3 | $13.8M | Buy |
74,070
+5,324
| +8% | +$928K | 0.04% | 318 |
|
|
2017
Q2 | $11.9M | Sell |
68,746
-1,111
| -2% | -$178K | 0.03% | 337 |
|
|
2017
Q1 | $10.7M | Buy |
69,857
+7,029
| +11% | +$1.03M | 0.03% | 338 |
|
|
2016
Q4 | $9.26M | Sell |
62,828
-54,761
| -47% | -$7.93M | 0.03% | 324 |
|
|
2016
Q3 | $14.9M | Sell |
117,589
-39,032
| -25% | -$4.71M | 0.04% | 253 |
|
|
2016
Q2 | $17.7M | Sell |
156,621
-81,170
| -34% | -$8.42M | 0.05% | 242 |
|
|
2016
Q1 | $24.8M | Buy |
237,791
+40,886
| +21% | +$3.91M | 0.08% | 199 |
|
|
2015
Q4 | $22.2M | Sell |
196,905
-40,419
| -17% | -$4.47M | 0.07% | 208 |
|
|
2015
Q3 | $26M | Sell |
237,324
-18,659
| -7% | -$2M | 0.08% | 190 |
|
|
2015
Q2 | $24.5M | Sell |
255,983
-13,648
| -5% | -$1.28M | 0.07% | 202 |
|
|
2015
Q1 | $25.1M | Buy |
269,631
+4,793
| +2% | +$419K | 0.08% | 198 |
|
|
2014
Q4 | $21.7M | Buy |
264,838
+24,900
| +10% | +$1.91M | 0.06% | 215 |
|
|
2014
Q3 | $15.4M | Buy |
239,938
+76,798
| +47% | +$4.7M | 0.05% | 258 |
|
|
2014
Q2 | $9.92M | Buy |
+163,140
| New | +$9.63M | 0.03% | 302 |
|
Other funds holding ICUI
NI
Eaton Vance Management's ICUI Position: Q3 2022 in Review
Eaton Vance Management reduced its ICU Medical (ICUI) stake by 20% in Q3 2022, selling an estimated $9.11M and leaving 216,409 shares worth $32.6M. The position accounts for 0.05% of the portfolio, ranked #342.
Eaton Vance Management first reported a position in ICUI in Q2 2014 and has held it in 34 quarters since. The position peaked at $60.9M in Q4 2020. 243 funds tracked by Wall St. Rank hold ICUI as of Q3 2022.
- Eaton Vance Management held 216,409 shares of ICU Medical worth $32.6M as of Q3 2022.
- Eaton Vance Management sold 54,731 ICU Medical shares in Q3 2022, an estimated $9.11M.
- ICU Medical made up 0.05% of Eaton Vance Management's portfolio in Q3 2022, its #342 holding.
- Eaton Vance Management first reported a position in ICU Medical in Q2 2014 and has held it in 34 quarters since.
- Eaton Vance Management's ICU Medical position peaked at $60.9M in Q4 2020.
- 243 funds tracked by Wall St. Rank held ICU Medical as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.